C14ORF143 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.193200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.433200E-01
Normal-vs-Stage2
1.930770E-01
Normal-vs-Stage3
8.005200E-01
Normal-vs-Stage4
3.295000E-01
Stage1-vs-Stage2
1.638160E-01
Stage1-vs-Stage3
5.151000E-01
Stage1-vs-Stage4
3.935800E-01
Stage2-vs-Stage3
8.311800E-02
Stage2-vs-Stage4
8.198600E-01
Stage3-vs-Stage4
1.650630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.151600E-01
Normal-vs-AfricanAmerican
4.787800E-01
Normal-vs-Asian
3.604600E-01
Caucasian-vs-AfricanAmerican
3.017000E-01
Caucasian-vs-Asian
7.961800E-01
AfricanAmerican-vs-Asian
4.785400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.927830E-01
Normal-vs-Female
2.630000E-01
Male-vs-Female
6.823000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.203000E-01
Normal-vs-Age(41-60Yrs)
9.209900E-02
Normal-vs-Age(61-80Yrs)
3.166600E-01
Normal-vs-Age(81-100Yrs)
2.273400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.164400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.742800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.710000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.070300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.043000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.114600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.412000E-01
Normal-vs-Daily Drinker
2.402600E-01
Normal-vs-Weekly Drinker
5.458000E-01
Normal-vs-Occasional Drinker
4.785900E-02
Normal-vs-Social Drinker
1.626630E-01
Non Drinker-vs-Daily Drinker
9.625400E-01
Non Drinker-vs-Weekly Drinker
3.570000E-01
Non Drinker-vs-Occasional Drinker
3.542600E-01
Non Drinker-vs-Social Drinker
7.226200E-01
Daily Drinker-vs-Weekly Drinker
3.940000E-01
Daily Drinker-vs-Occasional Drinker
3.380000E-01
Daily Drinker-vs-Social Drinker
7.573400E-01
Weekly Drinker-vs-Occasional Drinker
8.743800E-02
Weekly Drinker-vs-Social Drinker
5.318800E-01
Occasional Drinker-vs-Social Drinker
1.581770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.843800E-01
Normal-vs-Grade 2
7.676400E-01
Normal-vs-Grade 3
2.303000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.104400E-01
Grade 1-vs-Grade 3
5.103200E-03
Grade 1-vs-Grade 4
8.843800E-01
Grade 2-vs-Grade 3
8.193500E-02
Grade 2-vs-Grade 4
7.676400E-01
Grade 3-vs-Grade 4
2.303000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.974000E-01
Normal-vs-NonDiabetic
2.082000E-01
Diabetic-vs-NonDiabetic
3.388800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.540990E-01
Normal-vs-NoPancreatitis
2.435600E-01
Pancreatitis-vs-NoPancreatitis
9.395800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.098400E-01
Normal-vs-N1
2.028600E-01
N0-vs-N1
7.621500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.329800E-02
Normal-vs-TP53-NonMutant
6.742000E-01
TP53-Mutant-vs-TP53-NonMutant
8.79360000372031E-08
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
